Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform

Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform

The COVID-19 pandemic has reached over 100 million worldwide. Due to the multi-targeted nature of the virus, it is clear that drugs providing anti-COVID-19 effects need to be developed at an accelerated rate, and a combinatorial approach may stand to be more successful than a single drug therapy. Am...

Full description

Bibliographic Details
Main Authors: Kaushik Chakravarty, Victor G. Antontsev, Maksim Khotimchenko, Nilesh Gupta, Aditya Jagarapu, Yogesh Bundey, Hypatia Hou, Neha Maharao, Jyotika Varshney
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Molecules
Subjects:
COVID-19
ACE inhibitors
calcium channel blockers
artificial intelligence
drug repurposing
Online Access:https://www.mdpi.com/1420-3049/26/7/1912

Internet

https://www.mdpi.com/1420-3049/26/7/1912

Similar Items